Spring direct naar de hoofdnavigatie of de inhoud

Bart Jan Niestadt

Patent attorney

“The critical factors for a successful IP policy are different for each business. Knowing these factors is key.”
Home / Experts / Bart Jan Niestadt

Bart Jan Niestadt

Bart Jan Niestadt

  • Hightech & Electronics
  • European Patent Attorney
  • Dutch Patent Attorney
  • Belgian Patent Attorney
  • Senior Associate

Bart Jan Niestadt has been active as patent attorney from 2001 onwards. Before that, he had worked several years in the telecommunications industry, amongst others on network optimization and enhancements to network infrastructure, for BT-Infonet and Verizon Communications.

Bart Jan completed his studies of Applied Physics at Eindhoven University of Technology in 1997. His studies included an internship at ArizonaStateUniversity and a research project at Shell laboratories (SRTCA) in Amsterdam.

More information about Bart Jan

Throughout his career, Bart Jan has gained experience in litigation and opposition proceedings, and he is involved in a number of pending infringement cases in the telecommunications industry. In addition, he has a broad experience in preparing and prosecuting applications for small and large-sized enterprises in a wide range of technologies, and has developed commercial skills through a number of commercial activities and responsibilities over the years.

Working experience

  • Patent Attorney, V.O. (2011-present)
  • Patent Attorney, AOMB (2001-2011), head of Sittard office, AOMB (2009-2011)
  • Interxion (2001)
  • Verizon Communications (formerly: MCI-Worldcom) (2000-2001)
  • BT-Infonet (formerly: AT&T-Unisource) (1997-1999)

Education

  • MSc in Applied Physics, Eindhoven University of Technology (1997)

Publications

  • B.J. Niestadt: Twophase Flow in Cracking Furnaces. Residence Time in Annular Dispersed Flow and Bubble Detachment in Turbulent Flow, Eindhoven University of Technology, December 17, 1997.
  • H.J.S. Fernando, P. Peeters, A. Robles, and B. Niestadt: Laboratory Modeling of Microbursts, 1st AIAA Theoretical Fluid Mechanics Meeting, June 17-20, 1996, New Orleans, AIAA Paper 96-2149.

Languages

  • English
  • Dutch

Also see these experts

Kasper Haak

Kasper Haak

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
Isabelle Surdej

Isabelle Surdej

  • European Patent Attorney
  • Associate
More experts

News

HEMA faces claim by Levi’s over stitching

Denim giant Levi’s recently won a court case in Belgium against the well-known department store HEMA about the shape of the stitches on the rear of its jeans.Continue reading

Brexit

The impact of Brexit on IP rights

The United Kingdom (UK) is expected to leave the European Union on 29 March 2019, with or without a deal. The British Parliament has expressly stated that the existing IP rights that have been established within the EU context will be guaranteed in either case. Below you will find a brief overview of the impact […]Continue reading

Supplier must warn of potential patent infringement in another country

Imagine that you sell a product that does not fall under the Netherlands’ patent protection to a customer, but your customer then exports the product to Germany where it is protected by a patent. How does this affect your liability?Continue reading

Events

Idea, IP & Innovation (3i-) Event

High Tech Campus Eindhoven, High Tech Campus, Eindhoven

On Tuesday 18 April TW.nl organizes the second edition of the 3i-Event. During this inspiring afternoon about Ideas, Intellectual property and Innovation on the Hightech Campus in Eindhoven, R&D professionals, startups and SME entrepreneurs will learn how to set up a successful IP strategy for their companies. More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event